click below
click below
Normal Size Small Size show me how
continence meds
WOCN program
| Term | Definition |
|---|---|
| anticholinergic | can contribute to constipation, prolong colonic transport time can cause urinary retention by reducing detrusor contraction strength |
| antimuscarinic | REDUCES detrusor OVERACTIVITY and increases capacity used with OAB and neurogenic bladder SE's include dry mouth and constipation |
| alpha-1 -adrenergic antagonist | reduces urethral pressure used in BPH and neurogenic bladder SE hypotension |
| cholinergic | STIMULATES detrusor |
| beta-3 adrenergic agonist | RELAXES DETRUSOR, increase storage used with neurogenic bladder and OAB SE's less dry mouth, new or worsen HTN |
| osmotic laxatives | softens stool, promotes peristalsis |
| stimulant laxative | increases peristalsis, increases water absorption in large intestine |
| bulk forming laxatives | increases bulk, increases water absorption |
| cholestyramine | binds bile acids which have a promotility effect on bowel |
| skeletal muscle relaxant | reduces muscle tone in rhabdosphincter and periurethral muscles neurogenic bladder |
| alpha adrenergic agonist | promotes urethral sphincter closure, increases muscle tone in bladder neck includes cold meds SE's HTN, nervousness |
| 5-alpha reductase inhibitors | reduces size of prostate |
| meds for BPH | 5-alpha reductase inhibitors alpha-1 -adrenergic antagonist |
| meds for OAB | antimuscarinic beta-3 adrenergic agonist anticholinergic |
| meds for neurogenic bladder | alpha-1 -adrenergic antagonist antimuscarinic anticholinergic beta-3 adrenergic agonist antispasmodic |
| meds that reduce detrusor activity | antimuscarinic anticholinergic beta-3 adrenergic agonist |
| reduces urethral pressure | alpha blockers/antagonist antispasmodic |
| increases bladder neck and urethra sphincter tone | alpha agonist |